J Hardt1, S Mai2, C Weiß3, Peter Kienle4, J Magdeburg1. 1. Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany. 2. Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. 3. Department of Medical Statistics, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. 4. Department of Surgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68135, Mannheim, Germany. peter.kienle@umm.de.
Abstract
PURPOSE: Chemoradiotherapy is the standard treatment for squamous cell anal cancer. Salvage abdominoperineal resection (APR) is usually reserved for patients presenting with recurrent or persistent disease. Aim of our study was to review the outcomes of salvage surgery and perineal wound healing with or without a vertical rectus abdominis myocutaneous (VRAM) flap in a single institution over a 6-year period. METHODS: Data of all patients with biopsy-proven squamous cell anal cancer treated with chemoradiation at the University Medical Center Mannheim were recorded prospectively. Medical records of all patients who underwent salvage surgery for anal carcinoma between June 2008 and June 2014 were reviewed with regard to surgical and oncological outcomes. RESULTS: One hundred twenty-four patients received chemoradiation with a 5-year overall survival of 79 %. Seventeen patients required (salvage) APR for recurrent (n = 8), persistent (n = 7), or primary anal carcinoma (n = 2). Median overall survival was 33.4 months. Median duration until completion of perineal wound healing was shorter in the VRAM group (17 vs. 24.5 weeks; p = 0.0541). CONCLUSIONS: Salvage APR has a reasonable chance of long-time survival. Perineal reconstruction with a VRAM flap may reduce the duration until completion of perineal wound healing.
PURPOSE: Chemoradiotherapy is the standard treatment for squamous cell anal cancer. Salvage abdominoperineal resection (APR) is usually reserved for patients presenting with recurrent or persistent disease. Aim of our study was to review the outcomes of salvage surgery and perineal wound healing with or without a vertical rectus abdominis myocutaneous (VRAM) flap in a single institution over a 6-year period. METHODS: Data of all patients with biopsy-proven squamous cell anal cancer treated with chemoradiation at the University Medical Center Mannheim were recorded prospectively. Medical records of all patients who underwent salvage surgery for anal carcinoma between June 2008 and June 2014 were reviewed with regard to surgical and oncological outcomes. RESULTS: One hundred twenty-four patients received chemoradiation with a 5-year overall survival of 79 %. Seventeen patients required (salvage) APR for recurrent (n = 8), persistent (n = 7), or primary anal carcinoma (n = 2). Median overall survival was 33.4 months. Median duration until completion of perineal wound healing was shorter in the VRAM group (17 vs. 24.5 weeks; p = 0.0541). CONCLUSIONS: Salvage APR has a reasonable chance of long-time survival. Perineal reconstruction with a VRAM flap may reduce the duration until completion of perineal wound healing.
Authors: V O'Dowd; J P Burke; E Condon; D Waldron; N Ajmal; J Deasy; D A McNamara; J C Coffey Journal: Tech Coloproctol Date: 2014-05-07 Impact factor: 3.781
Authors: Caprice K Christian; Mary R Kwaan; Rebecca A Betensky; Elizabeth M Breen; Michael J Zinner; Ronald Bleday Journal: Dis Colon Rectum Date: 2005-01 Impact factor: 4.585
Authors: Eric D Wang; Nicole Conkling; Xiaoti Xu; Hueylan Chern; Emily Finlayson; Madhulika G Varma; Scott L Hansen; Robert D Foster; William Y Hoffman; Hani Sbitany Journal: Plast Reconstr Surg Date: 2015-01 Impact factor: 4.730
Authors: Dan E Schiller; Bernard J Cummings; Sundeep Rai; Lisa W Le; Linda Last; Phil Davey; Alexandra Easson; Andrew J Smith; Carol J Swallow Journal: Ann Surg Oncol Date: 2007-07-20 Impact factor: 5.344
Authors: Bernhard Fankhaenel; Joerg Zimmer; Dorothea Bleyl; Eric Puffer; Andreas Schreiber; Thomas Kittner; Helmut Witzigmann; Sigmar Stelzner Journal: Int J Colorectal Dis Date: 2019-10-22 Impact factor: 2.571
Authors: Beatrice Pessia; Lucia Romano; Antonio Giuliani; Gianni Lazzarin; Francesco Carlei; Mario Schietroma Journal: Ann Med Surg (Lond) Date: 2020-05-12